Immunophotonics
Pharmaceuticals company with a recent SEC Form D offering.
Pharmaceuticals company headquartered in ST. LOUIS, MISSOURI. Filed SEC Form D on 20260904 for a $10.1M Regulation D offering.
Biotech
📍 ST. LOUIS, MISSOURI
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Immunophotonics going public?
No. Immunophotonics is private and has not filed to go public. There is no S-1 on file.
What is Immunophotonics' valuation in 2026?
No confirmed valuation is on record for Immunophotonics. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Immunophotonics filed an S-1?
No public S-1 is on file for Immunophotonics.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Growth
Filed SEC Form D on 20260904 for $10.1M Regulation D offering
Last Round
Form D filing — $10.15M (20260904)
Fundraising Status
Form D filing · $10.15M
privateTotal raised $10.15M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $10.15M | 20260904 | — | — |
Vertical Intelligence — Biotech / Gene Therapy
Registered trials
2
2 active · 0 recruiting
Lead phase
Phase 3
most advanced registered study
Focus areas
Metastatic Solid Tumor
Colon Cancer · Nonsmall Cell Lung Cancer
Latest trial start
2026-05
Talent Signal
No public careers page or job board could be found for Immunophotonics as of 2026-09-09. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.